002086.SZ
东方海洋
SZSE · Consumer Defensive · A 农林牧渔 · CN
CNY 2.01
+0.50%Aug 25, 2026, 09:52 UTC
Dongfang Ocean reported a net loss of 48.2517 million yuan for the first half of 2026, compared with a loss of 71.0144 million yuan in the same period of 2025.
Source:Aug 6, 2026, 09:08 UTC
Dongfang Ocean's subsidiary Zhishu Biotechnology Co., Ltd. obtained a medical device registration certificate from the Shandong Provincial Drug Administration for its self-developed catecholamine metabolic profile detection kit (liquid chromatography-tandem mass spectrometry), valid until August 2, 2031, and the product was approved for market.
Source:Aug 3, 2026, 08:01 UTC
Dongfang Ocean's wholly-owned subsidiary Aiveke Biotechnology Co., Ltd. received a medical device registration certificate from the Shandong Provincial Drug Administration, allowing its Neutrophil Lipocalin (HNL) Assay Kit (Fluorescence Immunochromatography) to be marketed for in vitro quantitative determination of HNL content in human whole blood and serum.
Source:Jul 27, 2026, 07:47 UTC
Aiweike Biotechnology Co., Ltd., a wholly-owned subsidiary of Dongfang Ocean, obtained a medical device registration certificate from Shandong Provincial Drug Administration for its neutrophil lipocalin (HNL) assay kit (magnetic particle chemiluminescence method).
Source: